Works matching IS 00912700 AND DT 2007 AND VI 47 AND IP 1

Results: 18

Vildagliptin Does Not Affect C-Peptide Clearance in Patients With Type 2 Diabetes.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 127, doi. 10.1177/0091270006295061

By:

Yan-Ling YH He;
Anne AH Horowitz;
Catherine CEW Watson;
James JEF Foley;
William WS Sallas;
Monica ML Ligueros-Saylan

Publication type:

Article

Systemic Availability of the Active Metabolite Hydroxy-Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 19, doi. 10.1177/0091270006293767

By:

Peter PHH Hinderling;
Adel AHK Karara;
Ben BT Tao;
Maria MP Pawula;
Ian IW Wilding;
Ming ML Lu

Publication type:

Article

Dose-Proportional Pharmacokinetics of d-threo-Methylphenidate After a Repeated-Action Release Dosage Form.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 64, doi. 10.1177/0091270006293757

By:

Dietrich DT Tuerck;
Silke SA Appel-Dingemanse;
Mojdeh MM Maboudian;
Francoise FP Pommier;
Yibin YW Wang;
Greg GS Sedek

Publication type:

Article

The Role of SN-38 Exposure, UGT1A1*28 Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 78, doi. 10.1177/0091270006295060

By:

Roshni RPR Ramchandani;
Yaning YW Wang;
Brian BPB Booth;
Amna AI Ibrahim;
John JRJ Johnson;
Atiqur AR Rahman;
Mehul MM Mehta;
Federico FI Innocenti;
Mark MJR Ratain;
Jogarao JVG Gobburu

Publication type:

Article

Oral Antidiabetic Drugs: Effect of Food on Absorption of Pioglitazone and Metformin From a Fixed-Dose Combination Tablet.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 48, doi. 10.1177/0091270006293756

By:

Aziz AK Karim;
Margaret MS Slater;
Dawn DB Bradford;
Lisa LS Schwartz;
Aziz AL Laurent

Publication type:

Article

Vildagliptin does not affect C-Peptide clearance in patients with type 2 diabetes.

Published in:

2007

By:

He YL;
Horowitz A;
Watson CE;
Foley JE;
Sallas W;
Ligueros-Saylan M

Publication type:

Journal Article

Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor.

Published in:

2007

By:

Bethke TD;
Böhmer GM;
Hermann R;
Hauns B;
Fux R;
Mörike K;
David M;
Knoerzer D;
Wurst W;
Gleiter CH

Publication type:

Journal Article

Population Pharmacokinetic-Based Dosing of Intravenous Busulfan in Pediatric Patients.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 101, doi. 10.1177/0091270006295789

By:

Brian BPB Booth;
Atiqur AR Rahman;
Ramzi RD Dagher;
Donna DG Griebel;
Shari SL Lennon;
David DF Fuller;
Chandra CS Sahajwalla;
Mehul MM Mehta;
Jogarao JVG Gobburu

Publication type:

Article

Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 94, doi. 10.1177/0091270006295202

By:

Anne AM Mannila;
Elina EK Kumpulainen;
Marko ML Lehtonen;
Marja MH Heikkinen;
Merja ML Laisalmi;
Terhi TS Salo;
Jarkko JR Rautio;
Jouko JS Savolainen;
Hannu HK Kokki

Publication type:

Article

Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 6, doi. 10.1177/0091270006295064

By:

Pamala PJ Jacobson;
Kathleen KG Green;
John JR Rogosheske;
Claudio CB Brunstein;
Breta BE Ebeling;
Todd TD DeFor;
Philip PM McGlave;
Daniel DW Weisdorf

Publication type:

Article

Effect of Polymorphic CYP3A5 Genotype on the Single-Dose Simvastatin Pharmacokinetics in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 87, doi. 10.1177/0091270006295063

By:

Kyoung-Ah KK Kim;
Pil-Whan PP Park;
Ock-Je OL Lee;
Dong-Kyun DK Kang;
Ji-Young JP Park

Publication type:

Article

Oral Antidiabetic Drugs: Bioavailability Assessment of Fixed-Dose Combination Tablets of Pioglitazone and Metformin. Effect of Body Weight, Gender, and Race on Systemic Exposures of Each Drug.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 37, doi. 10.1177/0091270006293755

By:

Aziz AK Karim;
Margaret MS Slater;
Dawn DB Bradford;
Lisa LS Schwartz;
Zhen ZZ Zhao;
Charlie CC Cao;
Aziz AL Laurent

Publication type:

Article

Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 121, doi. 10.1177/0091270006292626

By:

Jaime JRG Gonzalez;
Leopoldo LB Baiza-Duran;
Juan JQ Quintana-Hau;
Ruben RT Tornero-Montaño;
Gilberto GC Castaneda-Hernandez;
Mario MO Ortiz;
Felipe FA Alarcon-Oceguera;
Marco MB Beltran-Loustaunau;
Marco MC Cortez-Gastelum;
Jorge JG Garcidueñas-Mejia;
Pedro PG Gomez-Bastar;
Jesus JJ Jimenez-Roman;
Vincent VK Korder-Ortega;
Jose JP Paczka-Zapata;
Marina MT Torres-Segura;
Gustavo GV Velasco-Gallegos

Publication type:

Article

Pharmacokinetics and Safety of Ketorolac Following Single Intranasal and Intramuscular Administration in Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 13, doi. 10.1177/0091270006294597

By:

Sarah SDM McAleer;
Oneeb OM Majid;
Esther EV Venables;
Torsten TP Polack;
Muhammed MSS Sheikh

Publication type:

Article

Significant Pharmacokinetic and Pharmacodynamic Interaction of Warfarin With the NO-Independent sGC Activator HMR1766.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 70, doi. 10.1177/0091270006294540

By:

Heike HO Oberwittler;
Andreas AH Hirschfeld-Warneken;
Roland RW Wesch;
Hans HW Willerich;
Lenore LT Teichert;
Karl-Heinz KL Lehr;
Reinhard RD Ding;
Walter WEH Haefeli;
Gerd GM Mikus

Publication type:

Article

Dose-Proportional Intraindividual Single and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 26, doi. 10.1177/0091270006294529

By:

Thomas TDB Bethke;
Gabriele GMB Böhmer;
Robert RH Hermann;
Bernhard BH Hauns;
Richard RF Fux;
Klaus KM Mörike;
Michael MD David;
Dietrich DK Knoerzer;
Wilhelm WW Wurst;
Christoph CHG Gleiter

Publication type:

Article

Comparison of Inhibitory Effects of Irbesartan and Atorvastatin Treatment on the Renin Angiotensin System (RAS) in Veins: A Randomized Double-Blind Crossover Trial in Healthy Subjects.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 112, doi. 10.1177/0091270006294280

By:

Christoph CS Schindler;
K. KBB Brosnihan;
Carlos CMF Ferrario;
Peter PB Bramlage;
Ulf UM Maywald;
Rainer RK Koch;
Reinhard RO Oertel;
Wilhelm WK Kirch

Publication type:

Article

Single-Dose and Steady-State Pharmacokinetics of Fentanyl Buccal Tablet in Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2007, v. 47, n. 1, p. 56, doi. 10.1177/0091270006294129

By:

Mona MD Darwish;
Mary MK Kirby;
Philmore PR Robertson;
Edward EH Hellriegel;
John JGJ Jiang

Publication type:

Article